Followers | 10 |
Posts | 605 |
Boards Moderated | 0 |
Alias Born | 06/30/2014 |
Thursday, December 26, 2019 9:51:59 AM
Hello XXXX,
Enjoyed meeting you today too. Look forward to going to the Avalanche Brewery.
Are you the St George who got my late wife Gwenn’s Mercedes to run better in the mountains?
image1.jpeg
The biochem company I mentioned is Relmada Therapeutics RLMD on NASDAQ.
Three weeks ago it was under $30, they raised $115mm last week at $30 share in a secondary offering that was oversubscribed by 4 times pushing it to over $45 briefly. Venrock, the founding backers of Intel and Apple, invested $25mm in 800,000 + shares at $30. Since popping up to $45 it has drifted down slowly to about $40.
They since announced two new board members and issued stock options to all the directors at $43.70/ share. One of the new directors Eric Schmidt had previously invested about $380,000 in 55,000 shares ($6 and $9/ share) of the company in two offerings that I participated in last June and in October 2018. He is a PhD (biochem) from MIT was for 20 years a top ranked biotech analyst and banker at Cowan & Co. and currently the CFO of $4b Allogene ( ALLO)
I will forward an email
I recently sent to my veterinarian in Harlingen who treated my cat 9 months ago. I told her about Relmada back ($11) then but none of my e mails got thru to her.
Here are the press releases from the company website:
https://www.relmada.com/news-events/press-releases
It may drift down under $40 in the coming weeks, the chart looks weak short term:
https://stockcharts.com/h-sc/ui?s=RLMD
but I’m not selling.
The company doesn’t leak inside information so I never know when good news is coming. I suspect the next good news will be getting designated a ‘Breakthrough Therapy’ by the FDA (They are already fast tracked by the FDA) or another buy report from some brokerage firm. The first one was published last week by Guggenheim with an initial price target of $64 ( ‘$128 with a 50% certainty’ ) Their long term revenue projection of $1.2 billion supports my estimate of $300-$500/ share.
Let’s get together soon,
Merry Christmas Les
https://www.outtherecolorado.com/mountain-town-fire-takes-out-historic-building-internet-and-cell-service/
Recent RLMD News
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/20/2024 10:55:59 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 01:53:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:29:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:28:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/31/2024 11:28:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 09:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:11:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:00:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:28:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:28:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:28:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:27:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:27:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:27:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:05:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:01:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/11/2023 01:00:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/10/2023 09:18:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2023 12:53:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2023 08:47:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/06/2023 01:23:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:54:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2023 08:29:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 08:01:43 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM